Cargando…
12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations
BACKGROUND: Two formulations of investigational bivalent Clostridioides (Clostridium) difficile vaccine (QS-21 adjuvanted toxoid and toxoid-alone) were assessed for safety and immunogenicity in randomized studies in healthy adults 50–85 years of age. METHODS: The Phase 1 study of QS-21 adjuvanted to...
Autores principales: | Lawrence, Jody, Kitchin, Nicholas, Anderson, Annaliesa S, Pride, Michael W, Jansen, Kathrin U, Gruber, William C, Peng, Yahong, Yi, Kevin, Knirsch, Charles, Webber, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776042/ http://dx.doi.org/10.1093/ofid/ofaa439.057 |
Ejemplares similares
-
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years
por: Kitchin, Nicholas, et al.
Publicado: (2020) -
636. Immunogenicity, Safety and Tolerability of a Booster Dose of Clostridium difficile Vaccine and 4 Year Antibody Persistence
por: Remich, Shon A, et al.
Publicado: (2020) -
Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020) -
Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
por: Fortier, Louis-Charles
Publicado: (2018) -
Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)